Lymphoma

Managing follicular lymphoma means balancing remission with the constant fear of relapse. Explore the reality of living with a chronic, incurable cancer.

Columnist Linda Cohen explores the emotional toll of aging with lymphoma, the pressure of cosmetic trends, and finding beauty in enduring love.

A tribute to Erin Cummings, a pillar of the Hodgkin lymphome survivor community who mentored others with the wisdom and grace of a real-life Mr. Miyagi.

Once the reality set in that my sister was cancer-free and in remission, I realized I was unprepared for what life would look like after cancer.

My experience with small lymphocytic lymphoma for the past 16 years has taught me many lessons.

The FDA fully approved Tecartus for adult patients with relapsed or refractory mantle cell lymphoma based on high response rates in the ZUMA-2 trial.

An overview of stage 1 lymphocyte-rich Hodgkin lymphoma covers diagnosis, treatment options and side effects to help guide patient care decisions.

FDA approves Opdivo with AVD for stage 3 or 4 Hodgkin lymphoma after trial shows improved progression-free survival versus comparator in untreated patients.

Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable with chemotherapy and radiation, with additional therapies available if the disease returns.

Dr. Jonathan W. Friedberg says long-term data show 42% of treated follicular lymphoma patients achieved functional cure with chemoimmunotherapy.

A personal look at choosing to be a caregiver, the challenges faced, and the lessons learned while supporting a sister through years with cancer.

Ipsen has pulled Tazverik from all markets after a trial found risks of secondary blood cancers, affecting patients with follicular lymphoma and epithelioid sarcoma.

Resilience programs using mindfulness and cognitive behavioral strategies help cancer survivors manage their fear and stress, as well as adjust after treatment.

Living long-term with cancer means learning to live in chapters. There are calm chapters and uncertain ones. Seasons of stability and seasons of intervention.

Overview of nodular sclerosis Hodgkin lymphoma, including diagnosis, staging, treatment options by stage and possible side effects.

FDA removal of an exclusion allows Yescarta use in primary CNS lymphoma, showing safety and strong efficacy in relapsed disease.

Gratitude didn’t erase my fear, but it gave me something solid to stand on. It became the coping strategy I needed.

FDA accepted a new drug application for tirabrutinib in relapsed or refractory PCNSL.

Five years ago, I finished treatment and was determined to be no evidence of disease. Until my most recent CT scan, there’s been no sign of recurrence.

Riozzi Bodine shares how her daughter’s diagnosis inspired the launch of a foundation offering cold caps, wigs and caregiver support.

Most people think of anniversaries as happy things. But there are other anniversaries that commemorate less pleasant events. Some anniversaries are a mix of pleasant and unpleasant.

Hodgkin lymphoma is a cancer of the lymphatic system, which includes lymph nodes, the spleen and immune cells that help the body fight infection.

FDA expands access to CAR-T cell therapy for patients with relapsed or refractory PCNSL.

Losing my cat after years alongside my cancer journey reminded me how much his presence eased stress, anxiety and treatment days.

An expert explains FDA-approved Lymphir for relapsed or refractory CTCL, noting 36% response rate, manageable side effects and fast relief from itching.